Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial

BACKGROUND: Concurrent chemoradiotherapy is currently the standard of care for patients with locally advanced cervical cancer. However, even with the application of modern radiotherapy techniques, a considerable number of patients still develop distant metastases. PD-L1 inhibitors show good efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jie, Li, Chen, Cao, Yuanjie, Zhu, Li, Zhang, Bailin, You, Jinqiang, Hou, Hailing, Wang, Jing, Yuan, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295395/
https://www.ncbi.nlm.nih.gov/pubmed/35854236
http://dx.doi.org/10.1186/s12885-022-09866-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295395/
https://www.ncbi.nlm.nih.gov/pubmed/35854236
http://dx.doi.org/10.1186/s12885-022-09866-w

Ejemplares similares